Open AccessX-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells
Author(s) -
Tao Huang,
Qian Hao,
Yao Chen,
Xiucheng Li,
Weihua Gong,
Guangjian Jiang,
Wei Zhang,
Shuo Cheng,
XuHui Li,
Pengcheng Li
Publication year - 2017
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 1998-4138
pISSN - 0973-1482
DOI - 10.4103/0973-1482.203599
Subject(s) - xiap , inhibitor of apoptosis , protein kinase b , apoptosis , osteosarcoma , pi3k/akt/mtor pathway , cancer research , chemistry , programmed cell death , caspase , biology , biochemistry
Embelin is an active compound identified as a novel X-linked inhibitor of apoptosis protein (XIAP) inhibitor from the Embelia ribes that exhibits various medicinal effects including anti-inflammatory and anticancer activities. However, the therapeutic effect of Embelin to human osteosarcoma is not yet determined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom